Chronic Obstructive Pulmonary Disease (COPD) is recognized globally as a major public health concern, not only due to its high prevalence and mortality rates but also because of its severe impact on ...

Chronic Obstructive Pulmonary Disease (COPD) is a leading global cause of mortality and disease burden, with its prevalence rising due to air pollution, smoking exposure, and rapid population aging ...

Familial pulmonary fibrosis represented 13% of fibrotic ILD overall, with higher proportions in IPF (18%) and unclassifiable ILD (15%) than in SARD-ILD (9%). Across diagnostic subgroups, familial ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Oral nerandomilast doses of 9 mg and 18 mg were ...

Bexotegrast-treated patients demonstrated improvements in forced vital capacity (FVC) and reduced cough severity compared to placebo. Bexotegrast was well tolerated at 160 mg over 12 weeks of ...

SAN FRANCISCO — The investigational oral agent nerandomilast was superior to placebo at slowing the decline in forced vital capacity (FVC) among patients with progressive pulmonary fibrosis (PF), ...

Hypercapnic patients were best separated from normocapnic patients using thresholds for FVC% of 56% predicted and 33% predicted for FEV1%. Hypercapnia in patients with chronic obstructive pulmonary ...

Please provide your email address to receive an email when new articles are posted on . AI model lung function estimations agreed with spirometry. With the model, there were high area under the ...

COPD requires regular monitoring through tests like spirometry to assess the condition’s severity and aid in an individualized treatment plan. COPD is a progressive lung condition that makes breathing ...

In a large US cohort study, pre-pandemic severe obstructive lung function, as measured by spirometry, was linked to more than a twofold increased risk for severe COVID-19. Researchers analyzed the ...